Breaking News Instant updates and real-time market news.

PTGX

Protagonist Therapeutics

$11.10

4.08 (58.12%)

08:55
08/07/18
08/07
08:55
08/07/18
08:55

Protagonist to offer 2.75M shares, warrants via Securities Purchase Agreement

Protagonist Therapeutics announced in a regulatory filing that on August 6 it entered into a Securities Purchase Agreement with certain purchasers pursuant to which the company will offer to the purchasers, up to an aggregate of an aggregate of 2.75M shares of common stock at a negotiated purchase price of $8.00 per share, for aggregate gross proceeds to the company of approximately $22M, before deducting estimated offering expenses payable by the company. In a concurrent private placement, the company is selling warrants to purchase an aggregate of 2.75M shares of common stock. Each Warrant will be exercisable from the date of issuance of the common stock until the five-year anniversary of the closing date. Warrants to purchase 1.375M shares will have an exercise price of $10.00 per share and Warrants to purchase 1.375M shares will have an exercise price of $15.00 per share.

PTGX Protagonist Therapeutics
$11.10

4.08 (58.12%)

03/27/18
BMOC
03/27/18
NO CHANGE
Target $13
BMOC
Outperform
Protagonist Therapeutics price target lowered to $13 from $42 at BMO Capital
BMO Capital analyst M. Ian Somaiya slashed his price target on Protagonist Therapeutics (PTGX) to $13 following the announcement that the company is discontinuing its Phase 2b study of PTG-100 in patients with moderate to severe ulcerative colitis. Somaiya adds that his valuation is now driven by the risk-adjusted sales model for PTG-200, which "represents a higher probability clinical program with peak sales of over $2B". The analyst also notes that he continues to exclude the clinical data of PTG-300 from his model. Despite the steep price target revision, Somaiya keeps his Outperform rating and recommends that investors buy into the weakness after the PTG-100 clinical disappointment on anticipated PTG-200 data and the advancement of Johnson&Johnson (JNJ) - shared Stelara.
06/06/18
LEHM
06/06/18
DOWNGRADE
Target $8.5
LEHM
Equal Weight
Protagonist downgraded to Equal Weight from Overweight at Barclays
Barclays analyst Douglas Tsao downgraded Protagonist Therapeutics to Equal Weight and lowered his price target for the shares to $8.50 from $30. The analyst continues to see value in the company's pipeline assets, but does expect achievement of key catalysts until the second half of 2019. As such, the analyst sees greater near-term potential in small cap names with catalysts upcoming, such as Foamix (FOMX).
08/06/18
LEER
08/06/18
NO CHANGE
Target $21
LEER
Outperform
Protagonist price target raised to $21 after study re-analysis at Leerink
Leerink analyst Joseph P. Schwartz raised his price target on Protagonist Therapeutics shares to $21 from $13 after the company announced results from an independent blinded re-analysis of the Phase 2 PROPEL study of oral alpha-4-beta-7 integrin antagonist PTG-100 for the treatment of patients with ulcerative colitis. He maintains an Outperform rating on Protagonist shares.
08/06/18
LEER
08/06/18
NO CHANGE
Target $21
LEER
Outperform
Protagonist Therapeutics' PTG-100 'back on track,' says Leerink
Leerink analyst Joseph Schwartz says PTG-100 in Ulcerative colitis is "back on track," increasing his confidence in Protagonist Therapeutics' peptide technology platform. The analyst notes that the company reported this morning an unexpected, but very positive, turnaround of its lead program, PTG-100, and will now pursue late-stage clinical development, assuming a positive discussion with the FDA occurs in 2H. While it is unfortunate that the program lost some time when the data set was initially mis-scored and deemed futile when in fact today's news suggests that PTG-100 could have robust clinical efficacy, Schwartz believes that Protagonist's persistence to uncover the truth leading to the resuscitation of the program is positive. The analyst reiterates an Outperform rating on the stock and raised his price target on the shares to $21 from $13.

TODAY'S FREE FLY STORIES

01:35
11/14/18
11/14
01:35
11/14/18
01:35
General news
Asian Market Wrap: »

Asian Market Wrap:…

VAPO

Vapotherm

$0.00

(0.00%)

20:28
11/13/18
11/13
20:28
11/13/18
20:28
Syndicate
Vapotherm 4M share IPO priced at $14.00 »

The deal priced at the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 14

    Nov

M

Macy's

$35.77

-1.27 (-3.43%)

, APRN

Blue Apron

$1.22

-0.03 (-2.40%)

20:25
11/13/18
11/13
20:25
11/13/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

M

Macy's

$35.77

-1.27 (-3.43%)

APRN

Blue Apron

$1.22

-0.03 (-2.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

  • 28

    Nov

BWXT

BWX Technologies

$42.34

-1.849 (-4.18%)

20:24
11/13/18
11/13
20:24
11/13/18
20:24
Initiation
BWX Technologies initiated at Maxim »

BWX Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EIX

Edison International

$55.56

2.02 (3.77%)

20:22
11/13/18
11/13
20:22
11/13/18
20:22
Downgrade
Edison International rating change at Edward Jones »

Edison International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCG

PG&E

$32.70

-0.25 (-0.76%)

20:22
11/13/18
11/13
20:22
11/13/18
20:22
Downgrade
PG&E rating change at Edward Jones »

PG&E downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNCE

Jounce Therapeutics

$4.40

-0.06 (-1.35%)

20:21
11/13/18
11/13
20:21
11/13/18
20:21
Downgrade
Jounce Therapeutics rating change at JPMorgan »

Jounce Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 13

    Nov

MFGP

Micro Focus

$16.76

0.65 (4.03%)

20:17
11/13/18
11/13
20:17
11/13/18
20:17
Upgrade
Micro Focus rating change at Goldman Sachs »

Micro Focus upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BXS

BancorpSouth

$28.92

0.14 (0.49%)

20:15
11/13/18
11/13
20:15
11/13/18
20:15
Hot Stocks
BancorpSouth to acquire Merchants Trust for up to $43M in cash and stock deal »

BancorpSouth Bank…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RVI

Retail Value

$28.05

-0.13 (-0.46%)

20:13
11/13/18
11/13
20:13
11/13/18
20:13
Hot Stocks
Retail Value closes sale of International Drive Value Center for $26.2M »

On November 13, 2018,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BXS

BancorpSouth

$28.92

0.14 (0.49%)

20:12
11/13/18
11/13
20:12
11/13/18
20:12
Hot Stocks
BancorpSouth to acquire Casey Bancorp for up to $56.8M in cash and stock deal »

BancorpSouth Bank…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TI

Telecom Italia

$6.07

0.06 (1.00%)

19:27
11/13/18
11/13
19:27
11/13/18
19:27
Downgrade
Telecom Italia rating change at Morgan Stanley »

Telecom Italia downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HNHPF

Hon Hai Precision

$0.00

(0.00%)

19:25
11/13/18
11/13
19:25
11/13/18
19:25
Downgrade
Hon Hai Precision rating change at HSBC »

Hon Hai Precision…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RGLD

Royal Gold

$71.33

-0.17 (-0.24%)

19:23
11/13/18
11/13
19:23
11/13/18
19:23
Hot Stocks
Royal Gold increases quarterly dividend to 26.5c from 25c per share »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VZ

Verizon

$58.67

-0.05 (-0.09%)

, MSI

Motorola Solutions

$126.92

-0.01 (-0.01%)

19:16
11/13/18
11/13
19:16
11/13/18
19:16
Hot Stocks
Verizon discloses completion of its first 5G data transmission on a smartphone »

Verizon (VZ) - in…

VZ

Verizon

$58.67

-0.05 (-0.09%)

MSI

Motorola Solutions

$126.92

-0.01 (-0.01%)

SSNLF

Samsung

$0.00

(0.00%)

QCOM

Qualcomm

$54.19

-0.29 (-0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 13

    Nov

  • 26

    Nov

ORN

Orion Group

$4.59

0.26 (6.00%)

19:08
11/13/18
11/13
19:08
11/13/18
19:08
Hot Stocks
Orion Group awarded $8M contract »

Orion Group Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RENN

Renren

$1.53

0.08 (5.52%)

19:01
11/13/18
11/13
19:01
11/13/18
19:01
Hot Stocks
Renren to dispose of all assets in SNS business to Beijing Infinities »

Renren announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PETQ

PetIQ

$31.27

-1.77 (-5.36%)

, MTSI

Macom

$15.17

0.28 (1.88%)

19:01
11/13/18
11/13
19:01
11/13/18
19:01
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: PetIQ…

PETQ

PetIQ

$31.27

-1.77 (-5.36%)

MTSI

Macom

$15.17

0.28 (1.88%)

SVMK

SurveyMonkey

$11.33

-0.185 (-1.61%)

REZI

Resideo

$21.28

-0.06 (-0.28%)

LAUR

Laureate Education

$15.53

-0.41 (-2.57%)

VREX

Varex Imaging

$26.11

-0.65 (-2.43%)

SIVB

SVB Financial

$242.68

1.84 (0.76%)

CLD

Cloud Peak

$1.32

-0.12 (-8.33%)

ETSY

Etsy

$47.31

-3.33 (-6.58%)

MMM

3M

$198.40

1.31 (0.66%)

EGBN

Eagle Bancorp

$49.19

0.48 (0.99%)

GDEN

Golden Entertainment

$14.32

-0.46 (-3.11%)

AKBA

Akebia

$7.76

0.04 (0.52%)

AMRS

Amyris

$5.90

0.04 (0.68%)

QRHC

Quest Resource

$2.23

-0.01 (-0.45%)

SWCH

Switch

$9.27

-0.075 (-0.80%)

WIX

Wix.com

$91.30

2.83 (3.20%)

TLRY

Tilray

$111.25

-1.95 (-1.72%)

APRN

Blue Apron

$1.22

-0.03 (-2.40%)

RESN

Resonant

$2.88

-0.03 (-1.03%)

CDNA

CareDx

$25.49

-2.01 (-7.31%)

LADR

Ladder Capital

$17.58

-0.03 (-0.17%)

ED

Consolidated Edison

$79.14

0.48 (0.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 13

    Nov

  • 13

    Nov

  • 13

    Nov

  • 13

    Nov

  • 13

    Nov

  • 13

    Nov

  • 13

    Nov

  • 13

    Nov

  • 13

    Nov

  • 13

    Nov

  • 13

    Nov

  • 13

    Nov

  • 13

    Nov

  • 14

    Nov

  • 14

    Nov

  • 14

    Nov

  • 15

    Nov

  • 15

    Nov

  • 27

    Nov

  • 27

    Nov

  • 28

    Nov

  • 04

    Dec

  • 11

    Dec

  • 14

    Nov

  • 14

    Nov

  • 16

    Nov

  • 16

    Nov

BA

Boeing

$349.62

-7.31 (-2.05%)

18:58
11/13/18
11/13
18:58
11/13/18
18:58
Periodicals
Boeing, FAA mulls software fix for 737 Max, Bloomberg says »

Boeing and the FAA are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SFTBF

SoftBank

$0.00

(0.00%)

18:38
11/13/18
11/13
18:38
11/13/18
18:38
Periodicals
SoftBank invests additional $3B in WeWork, NY Times reports »

WeWork said that SoftBank…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GDEN

Golden Entertainment

$14.32

-0.46 (-3.11%)

18:32
11/13/18
11/13
18:32
11/13/18
18:32
Hot Stocks
Golden Entertainment CFO Charles Protell buys 13.3K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EAGL

Platinum Eagle Acquisition Corp.

$9.90

0.03 (0.30%)

18:29
11/13/18
11/13
18:29
11/13/18
18:29
Hot Stocks
Platinum Eagle Acquisition Corp to merge with Target Logistics Management »

Platinum Eagle…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LBRDK

Liberty Broadband

$82.54

0.16 (0.19%)

18:12
11/13/18
11/13
18:12
11/13/18
18:12
Conference/Events
Liberty Broadband to host investor meeting »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

LBRDA

Liberty Broadband

$82.52

0.22 (0.27%)

18:11
11/13/18
11/13
18:11
11/13/18
18:11
Conference/Events
Liberty Broadband to host investor meeting »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

SGEN

Seattle Genetics

$54.84

-0.18 (-0.33%)

18:10
11/13/18
11/13
18:10
11/13/18
18:10
Hot Stocks
Seattle Genetics granted FDA Orphan designation for Adcetris »

According to a post on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 01

    Dec

  • 03

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.